Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06652503 · ClinicalTrials.gov registry record · NA
The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program
A NA study of Depression and Anxiety, sponsored by Nova Southeastern University.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06652503: Recruiting NA study of Depression and Anxiety, sponsored by Nova Southeastern University.
NCT06652503 is a NA study of Depression and Anxiety that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 160 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06652503, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by Nova Southeastern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to provide a free 6-week, online psychological coaching program to NSU undergraduate students to help with anxiety, depression, and stress, while improving quality of life and healthy coping skills.
Primary Outcome
GAD-7 (Generalized Anxiety Disorder 7 scale): GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety
Conditions Studied
Interventions
- BEHAVIORAL online mental health coaching
Study Locations (1)
Florida
- Nova Southeastern University - Fort Lauderdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT06652503 shows while recruiting
NCT06652503 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (80% lower).
The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which online mental health coaching is the first listed.
NCT06652503 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06652503 about?
NCT06652503 is a clinical study titled "The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program". The purpose of this research study is to provide a free 6-week, online psychological coaching program to NSU undergraduate students to help with anxiety, depression, and stress, while improving quality of life and healthy coping skills.
What is the current status of trial NCT06652503?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-01-13. Estimated completion is 2026-09.
What conditions does trial NCT06652503 study?
This clinical trial studies the following conditions: Depression, Anxiety, Stress, Quality of Life, Well-being.
What interventions are being tested in trial NCT06652503?
The interventions under investigation include: online mental health coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT06652503?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06652503 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06652503's enrollment target sits among peer trials
160 237th of 679 higher than 439 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy